Stocks and Investing
Stocks and Investing
Fri, May 21, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Thu, May 20, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Brian Skorney Initiated (VTGN) at Buy and Held Target at $270 on, May 20th, 2021
Brian Skorney of Baird, Initiated "Vistagen Therapeutics, Inc." (VTGN) at Buy and Held Target at $270 on, May 20th, 2021.
Brian has made no other calls on VTGN in the last 4 months.
There is 1 other peer that has a rating on VTGN. Out of the 1 peers that are also analyzing VTGN, 0 agree with Brian's Rating of Hold.
This is the rating of the analyst that currently disagrees with Brian
- Andrew Tsai of "Jefferies" Initiated at Strong Buy and Held Target at $180 on, Thursday, February 18th, 2021
Contributing Sources